Clinical Trials Browser

Interventional × Small Cell Lung Carcinoma × Albumin-Bound Paclitaxel × Clear all

NCT02769832 2025-07-29

Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer

Phase 2 Completed

32 enrolled 12 charts

Small Cell Lung Carcinoma

NCT04060342 2022-08-18

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Phase 1 Terminated

BreastGastrointestinalGenitourinaryHead & NeckThoracic

Adenocarcinoma Of Esophagus, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Stomach Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT04210037 2022-07-12

Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer

Phase 1/2 Terminated

Small Cell Lung Carcinoma

NCT01840579 2021-06-22

MK-3475-011

Phase 1 Completed

57 enrolled 60 charts

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT04056949 2019-08-14

Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT02331251 2018-07-02

Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)

Phase 1/2 Terminated

BreastGastrointestinalSarcomaThoracic

Breast Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT03219762 2017-07-26

Nabster

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT00454324 2017-07-11

NRR

Phase 2 Terminated

30 enrolled 12 charts

Lung Neoplasms, Small Cell Lung Carcinoma

NCT02262897 2014-10-13

The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer

Phase 2 Unknown

Small Cell Lung Carcinoma